Taken together, these studies provide evidence that PD-associated mutations disrupt Nrf2 signaling through several direct mechanisms: reduced nuclear translocation, transcriptional suppression, protein destabilization, and interference with Nrf2’s DNA-binding activity. This evidence concerns the gene NFE2L2 and Parkinson disease.